List of Tables
Table 1. Antiviral Therapy Market Trends
Table 2. Antiviral Therapy Market Drivers & Opportunity
Table 3. Antiviral Therapy Market Challenges
Table 4. Antiviral Therapy Market Restraints
Table 5. Global Antiviral Therapy Revenue by Company (2019-2024) & (US$ Million)
Table 6. Global Antiviral Therapy Revenue Market Share by Company (2019-2024)
Table 7. Key Companies Antiviral Therapy Manufacturing Base Distribution and Headquarters
Table 8. Key Companies Antiviral Therapy Product Type
Table 9. Key Companies Time to Begin Mass Production of Antiviral Therapy
Table 10. Global Antiviral Therapy Companies Market Concentration Ratio (CR5 and HHI)
Table 11. Global Top Companies Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Antiviral Therapy as of 2023)
Table 12. Mergers & Acquisitions, Expansion Plans
Table 13. Global Antiviral Therapy Sales Value by Type: 2019 VS 2023 VS 2030 (US$ Million)
Table 14. Global Antiviral Therapy Sales Value by Type (2019-2024) & (US$ Million)
Table 15. Global Antiviral Therapy Sales Value by Type (2025-2030) & (US$ Million)
Table 16. Global Antiviral Therapy Sales Market Share in Value by Type (2019-2024) & (%)
Table 17. Global Antiviral Therapy Sales Market Share in Value by Type (2025-2030) & (%)
Table 18. Global Antiviral Therapy Sales Value by Application: 2019 VS 2023 VS 2030 (US$ Million)
Table 19. Global Antiviral Therapy Sales Value by Application (2019-2024) & (US$ Million)
Table 20. Global Antiviral Therapy Sales Value by Application (2025-2030) & (US$ Million)
Table 21. Global Antiviral Therapy Sales Market Share in Value by Application (2019-2024) & (%)
Table 22. Global Antiviral Therapy Sales Market Share in Value by Application (2025-2030) & (%)
Table 23. Global Antiviral Therapy Sales Value by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 24. Global Antiviral Therapy Sales Value by Region (2019-2024) & (US$ Million)
Table 25. Global Antiviral Therapy Sales Value by Region (2025-2030) & (US$ Million)
Table 26. Global Antiviral Therapy Sales Value by Region (2019-2024) & (%)
Table 27. Global Antiviral Therapy Sales Value by Region (2025-2030) & (%)
Table 28. Key Countries/Regions Antiviral Therapy Sales Value Growth Trends, (US$ Million): 2019 VS 2023 VS 2030
Table 29. Key Countries/Regions Antiviral Therapy Sales Value, (2019-2024) & (US$ Million)
Table 30. Key Countries/Regions Antiviral Therapy Sales Value, (2025-2030) & (US$ Million)
Table 31. AbbVie Inc. Basic Information List
Table 32. AbbVie Inc. Description and Business Overview
Table 33. AbbVie Inc. Antiviral Therapy Products, Services and Solutions
Table 34. Revenue (US$ Million) in Antiviral Therapy Business of AbbVie Inc. (2019-2024)
Table 35. AbbVie Inc. Recent Developments
Table 36. Abbott Basic Information List
Table 37. Abbott Description and Business Overview
Table 38. Abbott Antiviral Therapy Products, Services and Solutions
Table 39. Revenue (US$ Million) in Antiviral Therapy Business of Abbott (2019-2024)
Table 40. Abbott Recent Developments
Table 41. F. Hoffmann-La Roche Ltd Basic Information List
Table 42. F. Hoffmann-La Roche Ltd Description and Business Overview
Table 43. F. Hoffmann-La Roche Ltd Antiviral Therapy Products, Services and Solutions
Table 44. Revenue (US$ Million) in Antiviral Therapy Business of F. Hoffmann-La Roche Ltd (2019-2024)
Table 45. F. Hoffmann-La Roche Ltd Recent Developments
Table 46. Bristol-Myers Squibb Company Basic Information List
Table 47. Bristol-Myers Squibb Company Description and Business Overview
Table 48. Bristol-Myers Squibb Company Antiviral Therapy Products, Services and Solutions
Table 49. Revenue (US$ Million) in Antiviral Therapy Business of Bristol-Myers Squibb Company (2019-2024)
Table 50. Bristol-Myers Squibb Company Recent Developments
Table 51. Johnson & Johnson Services, Inc. Basic Information List
Table 52. Johnson & Johnson Services, Inc. Description and Business Overview
Table 53. Johnson & Johnson Services, Inc. Antiviral Therapy Products, Services and Solutions
Table 54. Revenue (US$ Million) in Antiviral Therapy Business of Johnson & Johnson Services, Inc. (2019-2024)
Table 55. Johnson & Johnson Services, Inc. Recent Developments
Table 56. Merck & Co., Inc. Basic Information List
Table 57. Merck & Co., Inc. Description and Business Overview
Table 58. Merck & Co., Inc. Antiviral Therapy Products, Services and Solutions
Table 59. Revenue (US$ Million) in Antiviral Therapy Business of Merck & Co., Inc. (2019-2024)
Table 60. Merck & Co., Inc. Recent Developments
Table 61. Gilead Sciences, Inc. Basic Information List
Table 62. Gilead Sciences, Inc. Description and Business Overview
Table 63. Gilead Sciences, Inc. Antiviral Therapy Products, Services and Solutions
Table 64. Revenue (US$ Million) in Antiviral Therapy Business of Gilead Sciences, Inc. (2019-2024)
Table 65. Gilead Sciences, Inc. Recent Developments
Table 66. GlaxoSmithKline plc Basic Information List
Table 67. GlaxoSmithKline plc Description and Business Overview
Table 68. GlaxoSmithKline plc Antiviral Therapy Products, Services and Solutions
Table 69. Revenue (US$ Million) in Antiviral Therapy Business of GlaxoSmithKline plc (2019-2024)
Table 70. GlaxoSmithKline plc Recent Developments
Table 71. Aurobindo Pharma Basic Information List
Table 72. Aurobindo Pharma Description and Business Overview
Table 73. Aurobindo Pharma Antiviral Therapy Products, Services and Solutions
Table 74. Revenue (US$ Million) in Antiviral Therapy Business of Aurobindo Pharma (2019-2024)
Table 75. Aurobindo Pharma Recent Developments
Table 76. AstraZeneca Basic Information List
Table 77. AstraZeneca Description and Business Overview
Table 78. AstraZeneca Antiviral Therapy Products, Services and Solutions
Table 79. Revenue (US$ Million) in Antiviral Therapy Business of AstraZeneca (2019-2024)
Table 80. AstraZeneca Recent Developments
Table 81. Key Raw Materials Lists
Table 82. Raw Materials Key Suppliers Lists
Table 83. Antiviral Therapy Downstream Customers
Table 84. Antiviral Therapy Distributors List
Table 85. Research Programs/Design for This Report
Table 86. Key Data Information from Secondary Sources
Table 87. Key Data Information from Primary Sources
Table 88. Business Unit and Senior & Team Lead Analysts
List of Figures
Figure 1. Antiviral Therapy Product Picture
Figure 2. Global Antiviral Therapy Sales Value, 2019 VS 2023 VS 2030 (US$ Million)
Figure 3. Global Antiviral Therapy Sales Value (2019-2030) & (US$ Million)
Figure 4. Antiviral Therapy Report Years Considered
Figure 5. Global Antiviral Therapy Players Revenue Ranking (2023) & (US$ Million)
Figure 6. The 5 and 10 Largest Manufacturers in the World: Market Share by Antiviral Therapy Revenue in 2023
Figure 7. Antiviral Therapy Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
Figure 8. Generic Drugs Picture
Figure 9. Branded Drugs Picture
Figure 10. Global Antiviral Therapy Sales Value by Type (2019 VS 2023 VS 2030) & (US$ Million)
Figure 11. Global Antiviral Therapy Sales Value Market Share by Type, 2023 & 2030
Figure 12. Product Picture of HIV
Figure 13. Product Picture of Hepatitis
Figure 14. Product Picture of Herpes
Figure 15. Product Picture of Virus Influenza
Figure 16. Product Picture of Others
Figure 17. Global Antiviral Therapy Sales Value by Application (2019 VS 2023 VS 2030) & (US$ Million)
Figure 18. Global Antiviral Therapy Sales Value Market Share by Application, 2023 & 2030
Figure 19. North America Antiviral Therapy Sales Value (2019-2030) & (US$ Million)
Figure 20. North America Antiviral Therapy Sales Value by Country (%), 2023 VS 2030
Figure 21. Europe Antiviral Therapy Sales Value (2019-2030) & (US$ Million)
Figure 22. Europe Antiviral Therapy Sales Value by Country (%), 2023 VS 2030
Figure 23. Asia Pacific Antiviral Therapy Sales Value (2019-2030) & (US$ Million)
Figure 24. Asia Pacific Antiviral Therapy Sales Value by Country (%), 2023 VS 2030
Figure 25. South America Antiviral Therapy Sales Value (2019-2030) & (US$ Million)
Figure 26. South America Antiviral Therapy Sales Value by Country (%), 2023 VS 2030
Figure 27. Middle East & Africa Antiviral Therapy Sales Value (2019-2030) & (US$ Million)
Figure 28. Middle East & Africa Antiviral Therapy Sales Value by Country (%), 2023 VS 2030
Figure 29. Key Countries/Regions Antiviral Therapy Sales Value (%), (2019-2030)
Figure 30. United States Antiviral Therapy Sales Value, (2019-2030) & (US$ Million)
Figure 31. United States Antiviral Therapy Sales Value by Type (%), 2023 VS 2030
Figure 32. United States Antiviral Therapy Sales Value by Application (%), 2023 VS 2030
Figure 33. Europe Antiviral Therapy Sales Value, (2019-2030) & (US$ Million)
Figure 34. Europe Antiviral Therapy Sales Value by Type (%), 2023 VS 2030
Figure 35. Europe Antiviral Therapy Sales Value by Application (%), 2023 VS 2030
Figure 36. China Antiviral Therapy Sales Value, (2019-2030) & (US$ Million)
Figure 37. China Antiviral Therapy Sales Value by Type (%), 2023 VS 2030
Figure 38. China Antiviral Therapy Sales Value by Application (%), 2023 VS 2030
Figure 39. Japan Antiviral Therapy Sales Value, (2019-2030) & (US$ Million)
Figure 40. Japan Antiviral Therapy Sales Value by Type (%), 2023 VS 2030
Figure 41. Japan Antiviral Therapy Sales Value by Application (%), 2023 VS 2030
Figure 42. South Korea Antiviral Therapy Sales Value, (2019-2030) & (US$ Million)
Figure 43. South Korea Antiviral Therapy Sales Value by Type (%), 2023 VS 2030
Figure 44. South Korea Antiviral Therapy Sales Value by Application (%), 2023 VS 2030
Figure 45. Southeast Asia Antiviral Therapy Sales Value, (2019-2030) & (US$ Million)
Figure 46. Southeast Asia Antiviral Therapy Sales Value by Type (%), 2023 VS 2030
Figure 47. Southeast Asia Antiviral Therapy Sales Value by Application (%), 2023 VS 2030
Figure 48. India Antiviral Therapy Sales Value, (2019-2030) & (US$ Million)
Figure 49. India Antiviral Therapy Sales Value by Type (%), 2023 VS 2030
Figure 50. India Antiviral Therapy Sales Value by Application (%), 2023 VS 2030
Figure 51. Antiviral Therapy Industrial Chain
Figure 52. Antiviral Therapy Manufacturing Cost Structure
Figure 53. Channels of Distribution (Direct Sales, and Distribution)
Figure 54. Bottom-up and Top-down Approaches for This Report
Figure 55. Data Triangulation
